Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.
All articles — 31662 total
PTC Therapeutics is less crowded than most of its closest rare-disease peers, yet its short position remains one of the heavier ones in the group with earnings five days away. Among the biotech names most correlated…
Sunrise Energy Metals heads into the final week of October with a sharp price collapse, rapidly rebuilding short interest, and a key institutional holder making an unusually large entry, three signals that point in…
Saudi Awwal Bank (1060), one of Saudi Arabia's largest listed lenders by market capitalisation, has dropped 6.2% over the past week to close at SAR 30.98, its sharpest weekly decline in several months. The move arrives…
SOI has drifted 8.4% lower over the past month and 1.7% over the past week, closing at 425.5p, yet the borrow market shows no sign of conviction from short sellers. That tension, a meaningful price slide with almost no…
DASA3 has already run well past the analyst consensus and well past the MSCI entry price, leaving the November 5 earnings release as the next event that could either validate the move or expose it. A note published…
HBM reports on October 29 having lost 21% in a month, with the stock now at CAD 30.76 and the copper sector under broad pressure heading into the print. A note published earlier today covered the week's peer-group…
Short sellers have rebuilt their position in WPM to the highest level in at least a year, with shares short climbing to 3.26 million, up 28% over the past month and nearly 4% on the week alone. The short position now…
EDR has shed 29% in a month and 10% in the past week, arriving at October 29's earnings report deeply discounted and firmly in sector-wide territory rather than a company-specific slide. The peer table confirms the…
Lundin Gold dropped 10% on the week to CAD 84.52, broadly in line with a sector-wide gold equity retreat, but the short interest build underneath that move is running at a pace well outside the ordinary. Among its…
UNM has lost 2.1% this week, slightly more than the median decline of around 1.4% for its closest insurance peers, and the shares have now shed 3.3% over the past month. That modest underperformance comes at the same…
Loblaw Companies Limited enters the final stretch before its November 19 results with a stock that has pulled back modestly on the week but sits on a strong one-month run, and where the lending market continues to tell…
XRPN (Evernorth Holdings) is a newly-listed stock where the borrow market tells a more dramatic story than anything else on the tape this week: short sellers are paying annualised rates above 500% to maintain positions…
Pasqal Holding SA heads into the final stretch of October with a contradictory setup: shorts are rebuilding fast, yet the borrow market is loosening and analysts who have just initiated coverage are pitching targets…
PURR heads into its November 4 earnings date with a stock down 37% over the past month, options markets turning firmly bullish, and a potential index-buying catalyst arriving at almost the same moment as the print. The…
RNW heads into its November 20 earnings with an unusual contrast at its core: options traders have turned notably more cautious in the past week, even as the stock sits flat and its sovereign-backed ownership structure…
Climb Bio heads into its November 6 earnings date with a notable disconnect: 14 analysts are uniformly bullish, short sellers hold a significant position at nearly 14% of the free float, and the stock has lost 28% in a…
WGS has shed 38% over the past month and another 16% in the last session alone, entering its November 3 earnings date with short sellers holding firm, options traders more defensive than usual, and the Street's price…
HKD heads into the final stretch of October with a contradictory setup: short sellers are covering at pace, yet the cost to borrow shares is rising sharply. The most eye-catching move this week is in borrowing costs.…
Summit Therapeutics arrives at its October 27 earnings release with shorts quietly stepping back, options traders leaning toward calls, and a binary FDA decision on ivonescimab sitting just weeks beyond the print. The…
An NVDA board member filed a string of large sales in early September. Independent Director Mark Stevens reported selling more than $300 million worth of Nvidia shares across several transactions between August 31 and…
